Selecting Multitarget Peptides for Alzheimer's Disease.
Selecting Multitarget Peptides for Alzheimer's Disease.
复制标题
阿尔茨海默病的多靶点多肽选择
DOI:
10.3390/biom12101386
复制
发表时间:
2022-09-27
期刊:
影响因子:
5.5
通讯作者:
中科院分区:
文献类型:
--
作者:
Alzheimer’s disease (AD) is a multifactorial disease with a complex pathogenesis. Developing multitarget drugs could be a powerful strategy to impact the progressive loss of cognitive functions in this disease. The purpose of this study is to select a multitarget lead peptide candidate among a series of peptide variants derived from the neutrophil granule protein cathepsin G. We screened eight peptide candidates using the following criteria: (1) Inhibition and reversion of amyloid beta (Aβ) oligomers, quantified using an enzyme-linked immunosorbent assay (ELISA); (2) direct binding of peptide candidates to the human receptor for advanced glycation end-products (RAGE), the Toll-like receptor 4 (TLR4) and the S100 calcium-binding protein A9 (S100A9), quantified by ELISA; (3) protection against Aβ oligomer-induced neuronal cell death, using trypan blue to measure cell death in a murine neuronal cell line; (4) inhibition of TLR4 activation by S100A9, using a human TLR4 reporter cell line. We selected a 27-mer lead peptide that fulfilled these four criteria. This lead peptide is a privileged structure that displays inherent multitarget activity. This peptide is expected to significantly impact cognitive decline in mouse models of Alzheimer’s disease, by targeting both neuroinflammation and neurodegeneration.
登录
查看更多内容
影响因子:
5.3
作者:
Otazu GK;Dayyani M;Badie B
通讯作者:
Badie B
影响因子:
9.9
作者:
Galasko, Douglas;Bell, Joanne;Aisen, Paul S.
通讯作者:
Aisen, Paul S.
影响因子:
15.1
作者:
Babcock, Alicia A.;Ilkjaer, Laura;Finsen, Bente
通讯作者:
Finsen, Bente
影响因子:
9.3
作者:
Stock AJ;Kasus-Jacobi A;Pereira HA
通讯作者:
Pereira HA
影响因子:
3.7
作者:
Kim HJ;Chang KA;Ha TY;Kim J;Ha S;Shin KY;Moon C;Nacken W;Kim HS;Suh YH
通讯作者:
Suh YH